Difference between revisions of "Ultrasound CEUS BC"
Jump to navigation
Jump to search
m |
|||
Line 22: | Line 22: | ||
*[[Media:04 12 2019 QIBA CEUS BC Call Summary-FINAL.pdf|April 12, 2019]] | *[[Media:04 12 2019 QIBA CEUS BC Call Summary-FINAL.pdf|April 12, 2019]] | ||
*[[Media:03 08 2019 QIBA CEUS BC Call Summary-FINAL-MA.pdf|March 8, 2019]] | *[[Media:03 08 2019 QIBA CEUS BC Call Summary-FINAL-MA.pdf|March 8, 2019]] | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
'''''[[US CEUS Call Summary Archive]]''''' | '''''[[US CEUS Call Summary Archive]]''''' | ||
Revision as of 14:34, 3 July 2019
- Co-chairs: Michalakis (Mike) A. Averkiou, PhD; Richard G. Barr, MD, PhD; Todd Erpelding, PhD, MSE
- RSNA Staff Support: Julie Lisiecki
Project Snapshot
The Contrast Enhanced Ultrasound Biomarker Committee (CEUS BC) seeks to develop a quantitative imaging profile for CEUS imaging.
Project Descriptions:
CEUS Biomarker Committee Proposal:
Recent Meetings
Approved Call Summaries:
CEUS Task Force (TF) Call Summaries
Working Documents
Statistical Reference Documents
Workflow Documents
Historical Background - Formation of the Group
Reference Materials
Original Proposal to the QIBA Steering Committee:
Vendor Press Release:
Presentations: